Lipid Droplets from Plants and Microalgae: Characteristics, Extractions, and Applications.

Plant and algal LDs are gaining popularity as a promising non-chemical technology for the production of lipids and oils. In general, these organelles are composed of a neutral lipid core surrounded by a phospholipid monolayer and various surface-associated proteins. Many studies have shown that LDs are involved in numerous biological processes such as lipid trafficking and signaling, membrane remodeling, and intercellular organelle communications. To fully exploit the potential of LDs for scientific research and commercial applications, it is important to develop suitable extraction processes that preserve their properties and functions. However, research on LD extraction strategies is limited. This review first describes recent progress in understanding the characteristics of LDs, and then systematically introduces LD extraction strategies. Finally, the potential functions and applications of LDs in various fields are discussed. Overall, this review provides valuable insights into the properties and functions of LDs, as well as potential approaches for their extraction and utilization. It is hoped that these findings will inspire further research and innovation in the field of LD-based technology.

Polysaccharides Produced by Microalgae

The class of polysaccharides is recognized to be of paramount importance in modern technology;the possible molecular chemodiversity of these biomaterials that can be found in microalgae can play an important role in industrial sectors such as food, pharmaceutical, cosmetic, nutraceutical, and aquaculture. Some species of microalgae are already commercially available and studies about their bioculturing are advanced, thus offering high-value products for commercial applications. In this chapter the results of a searching the literature from 2013 to 2019 has been conducted on the structural identification and characterization of polysaccharides from these microorganisms. This report has been restricted to species commercially available, which are well known and prone to possible utilization and will not cover any possible discovery about rare or new species. In addition, prompted by the recent sudden outbreak of COVID-19, some literature reports on antiviral potential of microalgae polysaccharides among the commercial species are underlined. The overall results of this analysis seem not encouraging about flourishing of new detailed knowledge of fine structural features of these polysaccharides. The situation is reflecting the historical one observed for the launch of polysaccharides in biotechnology since 1950s. Intensive studies on possible exploitation using crude or partially purified and hardly standardized biomass preexisted to more demanding applications with standardized preparations with possible applications in more demanding fields. Only an interdisciplinary effort can lead soon to research for new chemical knowledge on fine structural details that are necessary to increase possible extensions of applications of pure material. © Springer Nature Switzerland AG 2022.

Benefits of supplementation with microbial omega-3 fatty acids on human health and the current market scenario for fish-free omega-3 fatty acid

Background Growing evidence points to a link between specific fatty acids ingested through the diet and human health. Chain length, saturation degree, and position of double bonds in fatty acids determine their effect in humans. Omega-3 and omega-6 fatty acids have been recognized for their contribution to the prevention and/or treatment of diabetes, cancer, visual impairment, cardiovascular diseases, as well as neurological and musculoskeletal disorders. Scope and approach Humans cannot synthesize these fatty acids in sufficient amounts and need to absorb them through the diet. Oleaginous microalgae constitute a promising, sustainable source of such fatty acids, as they can accumulate up to 85% of lipids on a cell dry weight basis. Key findings and conclusions The present review summarizes the potential of oleaginous microalgae as a convenient, economical, and sustainable source of polyunsaturated fatty acids, and explores their beneficial role in human health. The growing prevalence of cardiovascular diseases and changing dietary preferences are driving the increasing demand for microbial omega-3 fatty acids. Following the COVID-19 pandemic, the importance of a healthy immune system has further strengthened the market for omega-3 fatty acids.

The Ability of Airborne Microalgae and Cyanobacteria to Survive and Transfer the Carcinogenic Benzo(a)pyrene in Coastal Regions.

Air pollution has been a significant problem threatening human health for years. One commonly reported air pollutant is benzo(a)pyrene, a dangerous compound with carcinogenic properties. Values which exceed normative values for benzo(a)pyrene concentration in the air are often noted in many regions of the world. Studies on the worldwide spread of COVID-19 since 2020, as well as avian flu, measles, and SARS, have proven that viruses and bacteria are more dangerous to human health when they occur in polluted air. Regarding cyanobacteria and microalgae, little is known about their relationship with benzo(a)pyrene. The question is whether these microorganisms can pose a threat when present in poor quality air. We initially assessed whether cyanobacteria and microalgae isolated from the atmosphere are sensitive to changes in PAH concentrations and whether they can accumulate or degrade PAHs. The presence of B(a)P has significantly affected both the quantity of cyanobacteria and microalgae cells as well as their chlorophyll a (chl a) content and their ability to fluorescence. For many cyanobacteria and microalgae, an increase in cell numbers was observed after the addition of B(a)P. Therefore, even slight air pollution with benzo(a)pyrene is likely to facilitate the growth of airborne cyanobacteria and microalgae. The results provided an assessment of the organisms that are most susceptible to cellular stress following exposure to benzo(a)pyrene, as well as the potential consequences for the environment. Additionally, the results indicated that green algae have the greatest potential for degrading PAHs, making their use a promising bioremediation approach. Kirchneriella sp. demonstrated the highest average degradation of B(a)P, with the above-mentioned research indicating it can even degrade up to 80% of B(a)P. The other studied green algae exhibited a lower, yet still significant, B(a)P degradation rate exceeding 50% when compared to cyanobacteria and diatoms.

Microalgal Carbon Dioxide (CO2) Capture and Utilization from the European Union Perspective

The increasing concentration of anthropogenic CO2 in the atmosphere is causing a global environmental crisis, forcing significant reductions in emissions. Among the existing CO2 capture technologies, microalgae-guided sequestration is seen as one of the more promising and sustainable solutions. The present review article compares CO2 emissions in the EU with other global economies, and outlines EU's climate policy together with current and proposed EU climate regulations. Furthermore, it summarizes the current state of knowledge on controlled microalgal cultures, indicates the importance of CO2 phycoremediation methods, and assesses the importance of microalgae-based systems for long-term storage and utilization of CO2. It also outlines how far microalgae technologies within the EU have developed on the quantitative and technological levels, together with prospects for future development. The literature overview has shown that large-scale take-up of technological solutions for the production and use of microalgal biomass is hampered by economic, technological, and legal barriers. Unsuitable climate conditions are an additional impediment, forcing operators to implement technologies that maintain appropriate temperature and lighting conditions in photobioreactors, considerably driving up the associated investment and operational costs.

Perspective: Multiomics and Machine Learning Help Unleash the Alternative Food Potential of Microalgae.

Food security has become a pressing issue in the modern world. The ever-increasing world population, ongoing COVID-19 pandemic, and political conflicts together with climate change issues make the problem very challenging. Therefore, fundamental changes to the current food system and new sources of alternative food are required. Recently, the exploration of alternative food sources has been supported by numerous governmental and research organizations, as well as by small and large commercial ventures. Microalgae are gaining momentum as an effective source of alternative laboratory-based nutritional proteins as they are easy to grow under variable environmental conditions, with the added advantage of absorbing carbon dioxide. Despite their attractiveness, the utilization of microalgae faces several practical limitations. Here, we discuss both the potential and challenges of microalgae in food sustainability and their possible long-term contribution to the circular economy of converting food waste into feed via modern methods. We also argue that systems biology and artificial intelligence can play a role in overcoming some of the challenges and limitations; through data-guided metabolic flux optimization, and by systematically increasing the growth of the microalgae strains without negative outcomes, such as toxicity. This requires microalgae databases rich in omics data and further developments on its mining and analytics methods.

Erythroprotective Potential of Phycobiliproteins Extracted from Porphyridium cruentum.

There are multiple associations between the different blood groups (ABO and RhD) and the incidence of oxidative stress-related diseases, such as certain carcinomas and COVID-19. Bioactive compounds represent an alternative to its prevention and treatment. Phycobiliproteins (PBP) are bioactive compounds present in the microalga Porphyridium cruentum and, despite its antioxidant activity, their inhibitory effect on hemolysis has not been reported. The aim of this work was to evaluate the erythroprotective potential of phycobiliproteins from P. cruentum in different blood groups. The microalga was cultured in F/2 medium under controlled laboratory conditions. Day 10 of culture was determined as the harvest point. The microalgal biomass was lyophilized and a methanolic (MetOH), Tris HCl (T-HCl), and a physiological solution (PS) ultrasound-assisted extraction were performed. Extract pigments were quantified by spectrophotometry. The antioxidant activity of the extracts was evaluated with the ABTS+•, DPPH•, and FRAP methods, finding that the main antioxidant mechanism on the aqueous extracts was HAT (hydrogen atom transfer), while for MetOH it was SET (single electron transfer). The results of the AAPH, hypotonicity, and heat-induced hemolysis revealed a probable relationship between the different antigens (ABO and RhD) with the antihemolytic effect, highlighting the importance of bio-directed drugs.

Antimicrobial therapeutics isolated from algal source: retrospect and prospect.

In the last few decades, attention on new natural antimicrobial compounds has arisen due to a change in consumer preferences and the increase in the number of resistant microorganisms. Algae are defined as photosynthetic organisms that demonstrate a wide range of adaptability to adverse environmental conditions like temperature extremes, photo-oxidation, high or low salinity, and osmotic stress. Algae are primarily known to produce large amounts of secondary metabolite against various kinds of pathogenic microbes. Among these algae, micro and microalgae of river, lake, and algae of oceanic origin have been reported to have antimicrobial activity against the bacteria and fungi of pathogenic nature. Various polar and non- polar extracts of micro- and macro algae have been used for the suppression of these pathogenic fungi. Apart from these, certain algal derivatives have also been isolated from these having antibacterial and antifungal potential. Among the bioactive molecules of algae, polysaccharides, sulphated polysaccharides, phyco-cyanobilins polyphenols, lectins, proteins lutein, vitamin E, B12 and K1, peptides, polyunsaturated fatty acids and pigments can be highlighted. In the present review, we will discuss the biological activity of these derived compounds as antifungal/ antibacterial agents and their most promising applications. A brief outline is also given for the prospects of these isolated phytochemicals and using algae as therapeutic in the dietary form. We have also tried to answer whether alga-derived metabolites can serve as potential therapeutics for the treatment of SARS-CoV-2 like viral infections too.

Culturing Microalgae from Nature: Simple Experiment During Pandemic Covid-19

Microalgae are protists with eukaryotic cell structures which can be found in aquatic ecosystems such as rivers, lakes, reservoirs, ponds, and oceans. The protist culture method can be considered as a technique to allow protists to grow in a certain controlled environment. The objective of this study was to determine the growth of microalgae in the different water sources A modified closed photo-bioreactor (bottle) was used in this research. The number of experiments was 130, each experiment comparing 5 different natural water resources which are well, pond, pool, paddle, river, tap water, and mineral water and tap water as control, all with 25 replications. Those bottles were put under the sun for 2 weeks. Every day, the colour changes were documented. The result showed that within 2 weeks, no colour changes for mineral and tap waters. On the fourth and fifth days, the watercolour of rivers, ponds, paddle, pools turn the greenish or murky brownish. This indicated the growth of microalgae in the bottle. The different colour indicates the different species or a group of species. This simple experiment able to be developed for practical work during pandemic Covid-19, when students have to study at home, but are still able to get their competence by small project-based learning. © The Authors, published by EDP Sciences.

The nanomolar affinity of C-phycocyanin from virtual screening of microalgal bioactive as potential ACE2 inhibitor for COVID-19 therapy.

The global pandemic of COVID-19 caused by SARS-CoV-2 has caused more than 400 million infections with more than 5.7 million deaths worldwide, and the number of validated therapies from natural products for treating coronavirus infections needs to be increased. Therefore, the virtual screening of bioactive compounds from natural products based on computational methods could be an interesting strategy. Among many sources of bioactive natural products, compounds from marine organisms, particularly microalgae and cyanobacteria, can be potential antiviral agents. The present study investigates bioactive antiviral compounds from microalgae and cyanobacteria as a potential inhibitor of SARS-CoV-2 by targeting Angiotensin-Converting Enzyme II (ACE2) using integrated in silico and in vitro approaches. Our in silico analysis demonstrates that C-Phycocyanin (CPC) can potentially inhibit the binding of ACE2 receptor and SARS-CoV-2 with the docking score of -9.7 kcal mol-1. This score is relatively more favorable than the native ligand on ACE2 receptor. Molecular dynamics simulation also reveals the stability interaction between both CPC and ACE2 receptor with a root mean square deviation (RMSD) value of 1.5 Å. Additionally, our in vitro analysis using the surface plasmon resonance (SPR) method shows that CPC has a high affinity for ACE2 with a binding affinity range from 5 to 125 µM, with KD 3.37 nM. This study could serve as a reference to design microalgae- or cyanobacteria-based antiviral drugs for prophylaxis in SARS-CoV-2 infections.

Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants.

Severe acute respiratory syndrome-Coronavirus 2 (SARS-CoV-2) can infect various human organs, including the respiratory, circulatory, nervous, and gastrointestinal ones. The virus is internalized into human cells by binding to the human angiotensin-converting enzyme 2 (ACE2) receptor through its spike protein (S-glycoprotein). As S-glycoprotein is required for the attachment and entry into the human target cells, it is the primary mediator of SARS-CoV-2 infectivity. Currently, this glycoprotein has received considerable attention as a key component for the development of antiviral vaccines or biologics against SARS-CoV-2. Moreover, since the ACE2 receptor constitutes the main entry route for the SARS-CoV-2 virus, its soluble form could be considered as a promising approach for the treatment of coronavirus disease 2019 infection (COVID-19). Both S-glycoprotein and ACE2 are highly glycosylated molecules containing 22 and 7 consensus N-glycosylation sites, respectively. The N-glycan structures attached to these specific sites are required for the folding, conformation, recycling, and biological activity of both glycoproteins. Thus far, recombinant S-glycoprotein and ACE2 have been produced primarily in mammalian cells, which is an expensive process. Therefore, benefiting from a cheaper cell-based biofactory would be a good value added to the development of cost-effective recombinant vaccines and biopharmaceuticals directed against COVID-19. To this end, efficient protein synthesis machinery and the ability to properly impose post-translational modifications make microalgae an eco-friendly platform for the production of pharmaceutical glycoproteins. Notably, several microalgae (e.g., Chlamydomonas reinhardtii, Dunaliella bardawil, and Chlorella species) are already approved by the U.S. Food and Drug Administration (FDA) as safe human food. Because microalgal cells contain a rigid cell wall that could act as a natural encapsulation to protect the recombinant proteins from the aggressive environment of the stomach, this feature could be used for the rapid production and edible targeted delivery of S-glycoprotein and soluble ACE2 for the treatment/inhibition of SARS-CoV-2. Herein, we have reviewed the pathogenesis mechanism of SARS-CoV-2 and then highlighted the potential of microalgae for the treatment/inhibition of COVID-19 infection.

Potential Psychoactive Effects of Microalgal Bioactive Compounds for the Case of Sleep and Mood Regulation: Opportunities and Challenges.

Sleep deficiency is now considered an emerging global epidemic associated with many serious health problems, and a major cause of financial and social burdens. Sleep and mental health are closely connected, further exacerbating the negative impact of sleep deficiency on overall health and well-being. A major drawback of conventional treatments is the wide range of undesirable side-effects typically associated with benzodiazepines and antidepressants, which can be more debilitating than the initial disorder. It is therefore valuable to explore the efficiency of other remedies for complementarity and synergism with existing conventional treatments, leading to possible reduction in undesirable side-effects. This review explores the relevance of microalgae bioactives as a sustainable source of valuable phytochemicals that can contribute positively to mood and sleep disorders. Microalgae species producing these compounds are also catalogued, thus creating a useful reference of the state of the art for further exploration of this proposed approach. While we highlight possibilities awaiting investigation, we also identify the associated issues, including minimum dose for therapeutic effect, bioavailability, possible interactions with conventional treatments and the ability to cross the blood brain barrier. We conclude that physical and biological functionalization of microalgae bioactives can have potential in overcoming some of these challenges.

Recent advances in the bio-application of microalgae-derived biochemical metabolites and development trends of photobioreactor-based culture systems.

Microalgae are microscopic algae in sizes ranging from a few micrometers to several hundred micrometers. On average, half of the oxygen in the atmosphere is produced by the photosynthetic process of microalgae, so the role of these microorganisms in the life cycle of the planet is very significant. Pharmaceutical products derived from microalgae and commercial developments of a variety of supplements extracted from them originate from a variety of their specific secondary metabolites. Many of these microalgae are a reservoir of unique biological compounds including carotenoids, antioxidants, fatty acids, polysaccharides, enzymes, polymers, peptides, pigments, toxins and sterols with antimicrobial, antiviral, antifungal, antiparasitic, anticoagulant, and anticancer properties. The present work begins with an introduction of the importance of microalgae in renewable fuels and biodiesel production, the development of healthy food industry, and the creation of optimal conditions for efficient biomass yield. This paper provides the latest research related to microalgae-derived substances in the field of improving drug delivery, immunomodulatory, and anticancer attributes. Also, the latest advances in algal biocompounds to combat the COVID-19 pandemic are presented. In the subject of cultivation and growth of microalgae, the characteristics of different types of photobioreactors, especially their latest forms, are fully discussed along with their advantages and obstacles. Finally, the potential of microalgae biomass in biotechnological applications, biofuel production, as well as various biomass harvesting methods are described.

Algal bioplastics: current market trends and technical aspects.

Abstract: Plastics are undebatably a hot topic of discussion across international forums due to their huge ecological footprint. The onset of COVID-19 pandemic has exacerbated the issue in an irreversible manner. Bioplastics produced from renewable sources are a result of lookout for sustainable alternatives. Replacing a ton of synthetic plastics with biobased ones reduces 1.8 tons CO2 emissions. Here, we begin with highlighting the problem statement-Plastic accumulation and its associated negative impacts. Microalgae outperforms plants and microbes, when used to produce bioplastic due to superior growth rate, non-competitive nature to food, and simultaneous wastewater remediation. They have minimal nutrient requirements and less dependency on climatic conditions for cultivation. These are the reasons for current boom in the algal bioplastic market. However, it is still not at par in price with the petroleum-based plastics. A brief market research has been done to better evaluate the current global status and future scope of algal bioplastics. The objective of this review is to propose possible solutions to resolve the challenges in scale up of bioplastic industry. Various bioplastic production technologies have been comprehensively discussed along with their optimization strategies. Overall studies discussed show that in order to make it cost competitive adopting a multi-dimensional approach like algal biorefinery is the best way out. A holistic comparison of any bio-based alternative with its conventional counterpart is imperative to assess its impact upon commercialization. Therefore, the review concludes with the life cycle assessment of bioplastics and measures to improve their inclusivity in a circular economy.

IN SILICO STUDY THE POTENTIAL OF MICROALGAE METABOLITES AS SARS-COV-2 INHIBITOR ON H-ACE2

The Corona Virus Disease 19 (COVID-19) caused by Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) was declared a global pandemic on March 11, 2020, and the number of cases is still growing. Antiviral drugs are needed for post-infection treatment. This study aims to determine microalgae compounds that can possibly be candidates for attachment inhibitors for SARS-CoV-2. The molecular docking method was used to determine the potential of microalgae metabolites based on the binding energy and the interaction of the compound with the H-ACE2 (Human Angiotensin Converting Enzyme II) receptor. The results showed that the three compounds with the lowest binding energy were Saringosterol (-10.76 kcal/mol), 24-Oxocholesterol acetate (-10.96 kcal/mol), and Dinosterol (-10.72 kcal/mol). These compounds had a lower binding energy value than the control ligand MLN-4760 (-8.02 kcal/mol). In addition, these three compounds can bind stably to the ACE2 binding site, as can be seen from the hydrogen bonds and hydrophobic interactions formed. Therefore, Saringosterol, 24-Oxocholesterol acetate, and Saringosterol merit further investigation regarding potential candidates for SARS-CoV-2 inhibitors. Additional study with molecular dynamics simulations and laboratory tests are needed to confirm this result.

Spirulina (Arthrospira Spp) as A Complementary Covid-19 Response Option: Early Evidence of Promise

The COVID-19 pandemic poses a profound threat to human health across the world. A growing body of evidence suggests that dietary choice can support pandemic response efforts. This paper asks whether spirulina, a type of edible microalgae, may offer a means of reducing COVID-19 risk. This question follows from spirulina's observed antiviral effects vis-a-vis other viral diseases. Questions about possible complementary therapies remain important due to the ongoing threat posed by COVID-19, given major gaps to vaccine rollout and the proliferation of mutant variants. The paper is based on a narrative review of the academic literature relevant to this question. The 25 papers identified were grouped and summarised, then discussed. The evidence reported suggests spirulina may have prophylactic and therapeutic efficacy against SARS-CoV-2 via several pathways, though further investigation is needed to verify the linkages identified. Incorporating spirulina into diet might thus offer a way to lower COVID-19 risk. This option may moreover be particularly helpful for at-risk populations, such as those in the Global South where many remain unvaccinated and food insecurity is widespread. This review reports findings in non-technical language and could inform actions by diverse stakeholders, including researchers, governments and households.

In silico evidence of antiviral activity against SARS-CoV-2 main protease of oligosaccharides from Porphyridium sp.

The coronavirus pandemic (COVID-19) has created an urgent need to develop effective strategies for prevention and treatment. In this context, therapies against protease Mpro, a conserved viral target, would be essential to contain the spread of the virus and reduce mortality. Using combined techniques of structure modelling, in silico docking and pharmacokinetics prediction, many compounds from algae were tested for their ability to inhibit the SARS-CoV-2 main protease and compared to the recent recognized drug Paxlovid. The screening of 27 algal molecules including 15 oligosaccharides derived from sulfated and non-sulphated polysaccharides, eight pigments and four poly unsaturated fatty acids showed high affinities to interact with the protein active site. Best candidates showing high docking scores in comparison with the reference molecule were sulfated tri-, tetra- and penta-saccharides from Porphyridium sp. exopolysaccharides (SEP). Structural and energetic analyses over 100 ns MD simulation demonstrated high SEP fragments-Mpro complex stability. Pharmacokinetics predictions revealed the prospects of the identified molecules as potential drug candidates.

In Situ Transesterification of Microbial Biomass for Biolubricant Production Catalyzed by Heteropolyacid Supported on Niobium

Lubricants are substances of the foremost importance in the modern world, as they are essential to the proper functioning of various mechanisms. Most lubricants, however, are still made from petroleum fractions. I light of this, and due to various environmental problems, the search for feasible biolubricants has become essential. This study obtained biolubricants through the in situ transesterification of microbial biomass, containing at least 20 wt% of lipids. The following two distinct biomasses were evaluated: the marine microalgae, Dunaliella salina, and the consortium of microalgae-fungi, Scenedesmus obliquus and Mucor circinelloides. Microbial oil from both biomasses presented a fatty acid profile with high amounts of oleic acid. The oil of D. salina had a lower content of polyunsaturated fatty acids relative to the microbial consortium profile, which indicates that this is a good configuration for increasing biolubricant oxidation resistance. The catalyst used was a Keggin-structure heteropolyacid supported on niobium, H3PMo12O40/Nb2O5, activated at 150 °C, which had high transesterification yields, notwithstanding the feedstocks, which were rich in free fatty acids. The performed transesterification reactions resulted in excellent yields, up to 97.58% and 96.80%, for marine microalgae and the consortium, respectively, after 6 h at 250 °C, with 10 wt% of catalyst (related to the lipid amount). As such, the (H3PMo12O40/Nb2O5) catalyst could become an attractive option for producing biolubricants from microbial biomass.

Antiviral Activities of Algal-Based Sulfated Polysaccharides.

An antiviral agent is urgently needed based on the high probability of the emergence and re-emergence of future viral disease, highlighted by the recent global COVID-19 pandemic. The emergence may be seen in the discovery of the Alpha, Beta, Gamma, Delta, and recently discovered Omicron variants of SARS-CoV-2. The need for strategies besides testing and isolation, social distancing, and vaccine development is clear. One of the strategies includes searching for an antiviral agent that provides effective results without toxicity, which is well-presented by significant results for carrageenan nasal spray in providing efficacy against human coronavirus-infected patients. As the primary producer of sulfated polysaccharides, marine plants, including macro- and microalgae, offer versatility in culture, production, and post-isolation development in obtaining the needed antiviral agent. Therefore, this review will describe an attempt to highlight the search for practical and safe antiviral agents from algal-based sulfated polysaccharides and to unveil their features for future development.

Remediation of Pesticides by Microalgae as Feasible Approach in Agriculture: Bibliometric Strategies

Pesticide treatment dramatically reduces crop loss and enhances agricultural productivity, promoting global food security and economic growth. However, owing to high accrual and persistent tendency, pesticides could create significant ecological consequences when used often. Lately, the perspective has transitioned to implementing biological material, environmentally sustainable, and economical strategies via bioremediation approaches to eradicate pesticides contaminations. Microalgae were regarded as a prominent option for the detoxification of such hazardous contaminants. Sustainable application and remediation strategies of pesticides pollutants in the agriculture system by microalgae from the past studies, and recent advancements were integrated into this review. Bibliometric strategies to enhance the research advancements in pesticide bioremediation by microalgae between 2010 and 2020 were implemented through critical comparative analysis of documents from Scopus and PubMed databases. As a result, this study identified a growing annual research trend from 1994 to 2020 (nScopus > nPubMed). Global production of pesticide remediation by microalgae demonstrated significant contributions from India (23.8%) and China (16.7%). The author’s keyword clustering was visualized using bibliometric software (VOSviewer), which revealed the strongest network formed by “microalgae”, “bioremediation”, “biodegradation”, “cyanobacteria”, “wastewater”, and “pesticide” as significant to the research topic. Hence, this bibliometric review will facilitate the future roadmap for many scholars and authors who were drawing attention to the burgeoning research on bioremediation of pesticides to counteract environmental impacts while maintaining food sustainability.